Attached files
| file | filename |
|---|---|
| 10-K - ANNUAL REPORT - Diffusion Pharmaceuticals Inc. | stratus_10k-123112.htm |
| EX-31.1 - CERTIFICATION - Diffusion Pharmaceuticals Inc. | stratus_10k-ex3101.htm |
| EX-10.15 - EMPLOYMENT AGREEMENT - Diffusion Pharmaceuticals Inc. | stratus_10k-ex1015.htm |
| EX-32.2 - CERTIFICATION - Diffusion Pharmaceuticals Inc. | stratus_10k-ex3202.htm |
| EX-31.2 - CERTIFICATION - Diffusion Pharmaceuticals Inc. | stratus_10k-ex3102.htm |
| EX-99.1 - IN ACCORDANCE WITH THE TEMPORARY HARDSHIP EXEMPTION PROVIDED BY RULE 201 OF REGULATION S-T, THE DATE BY WHICH THE INTERACTIVE DATA FILE IS REQUIRED TO BE SUBMITTED HAS BEEN EXTENDED BY SIX BUSINESS DAYS. - Diffusion Pharmaceuticals Inc. | stratus_10k-ex9901.htm |
Exhibit 32.1
CERTIFICATION PURSUANT TO SECTION 906 OF THE SARBANES OXLEY ACT OF 2002
Pursuant to 18 U.S.C. § 1350, as enacted by Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned officer of Stratus Media Group, Inc. (the “Company”) hereby certifies, to such officer’s knowledge:
(1) This Report on Form 10-K for the year ended December 31, 2012 (“Report”) fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.
| Date: April 16, 2013 | |
| /s/ Jerold Rubinstein | |
| Name: Jerold Rubinstein | |
| Title: Chief Executive Officer |
The foregoing certification is being furnished solely to accompany the Report pursuant to 18 U.S.C. § 1350, and is not being filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and is not to be incorporated by reference into any filing of the Company, whether made before or after the date hereof, regardless of any general incorporation language in such filing.